Financial Report: Abbvie 1Q Revenues: $13.5 billion (+4%) 1Q Earnings: $4.5 billion (+26%) Comments: Immunology portfolio sales were $6.1 billion, up 7% in the quarter. Humira revenues were $4.7 billion, down 2.7%. U.S. Humira revenues were $3.99 billion, an increase of 2.2 percent. Internationally, Humira revenues were $743 million, a down of 22.6%, due to biosimilar competition. Global Skyrizi sales were $940 million, an increase of 63.7%. Global Rinvoq revenues were $465 million, an increa...